CDIBA
CDIBA is a cytosolic phospholipase A2 (cPLA2) inhibitor. CDIBA inhibits the activation of cPLA2 in rat diaphragm tissue. CDIBA reduces the level of mitochondrial reactive oxygen species in rat diaphragm tissue after prolonged mechanical ventilation. CDIBA attenuates protein degradation, muscle atrophy and decreased muscle strength in the diaphragm of rats after prolonged mechanical ventilation. CDIBA can be used in studies related to ventilator-induced diaphragmatic dysfunction.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 479422-22-5
- Formel: C31H26ClNO3
- Molecular Weight:496.00
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Phospholipase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MC9 | Inhibition |
-8 %
Compound: 25
|
Inhibition of PGF2-alpha production in the presence of exogenous arachidonic acid in MC9 cell at 1.5 uM
Inhibition of PGF2-alpha production in the presence of exogenous arachidonic acid in MC9 cell at 1.5 uM
|
[PMID: 16392799] |
| MC9 | Inhibition |
81 %
Compound: 25
|
Inhibition of PGF2-alpha production in MC9 cells at 1.5 uM
Inhibition of PGF2-alpha production in MC9 cells at 1.5 uM
|
[PMID: 16392799] |
| MC9 | Inhibition |
96 %
Compound: 25
|
Inhibition of LTB4 production in MC9 cells at 1.5 uM
Inhibition of LTB4 production in MC9 cells at 1.5 uM
|
[PMID: 16392799] |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar rats (adult male, SPF level, 450-550 g, ventilator-induced diaphragm dysfunction model)[1]
-
Dosage:30 mg/kg (i.p. injection); 5 mg/kg/h (continuous i.v. infusion)
-
Administration:i.p. (single injection at ventilation onset); i.v. (continuous infusion; 12 hours)
-
Result:Significantly reduced cPLA2 activation in the diaphragm.
Decreased mitochondrial H2O2 production in the diaphragm.
Downregulated diaphragm calpain activity.
Reduced the expression of atrophy-related genes Atrogin-1 and MuRF-1 in the diaphragm.
Increased the cross-sectional area of slow-twitch and fast-twitch diaphragm muscle fibers.
Improved diaphragm contractile function, including increased maximal tetanic forces, elevated force-frequency curve responses, and enhanced fatigue tolerance, compared to untreated ventilated rats.
Chemical Information
-
CAS. Nr. 479422-22-5
-
Molecular Weight 496.00
-
Formel C31H26ClNO3
-
SMILES
O=C(O)C1=CC=C(OCCC=2C=3C=C(Cl)C=CC3N(C2C)C(C=4C=CC=CC4)C=5C=CC=CC5)C=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- CDIBA
- 479422-22-5
- Phospholipase
- Reactive Oxygen Species (ROS)
- mitochondrial reactive oxygen species
- cytosolic phospholipase A2
- protein degradation
- prolonged mechanical ventilation
- calpain activity
- rat diaphragm tissue
- diaphragm contractile force
- ventilator-induced diaphragm dysfunction
- muscle atrophy
- Inhibitor
- inhibitor
- inhibit